Oral delivery of peptides and proteins using lipid-based drug delivery systems

Abstract

Introduction: In order to successfully develop lipid-based drug delivery systems (DDS) for oral administration of peptides and proteins, it is important to gain an understanding of the colloid structures formed by these DDS, the mode of peptide and protein incorporation as well as the mechanism by which intestinal absorption of peptides and proteins is promoted.

Areas covered: The present paper reviews the literature on lipid-based DDS, employed for oral delivery of peptides and proteins and highlights the mechanisms by which the different lipid-based carriers are expected to overcome the two most important barriers (extensive enzymatic degradation and poor transmucosal permeability). This paper also gives a clear-cut idea about advantages and drawbacks of using different lipidic colloidal carriers ((micro)emulsions, solid lipid core particles and liposomes) for oral delivery of peptides and proteins.

Expert opinion: Lipid-based DDS are safe and suitable for oral delivery of peptides and proteins. Significant progress has been made in this area with several technologies on clinical trials. However, a better understanding of the mechanism of action in vivo is needed in order to improve the design and development of lipid-based DDS with the desired bioavailability and therapeutic profile.

Keywords::

• drug delivery systems
• (micro)emulsions
• liposomes
• mucoadhesion
• particles
• permeability
• SLN
• stability

Acknowledgements

The authors would like to acknowledge Drug Research Academy, Danish Agency for Science Technology and Innovation, as well as the NAnoMEChanical sensors and actuators, fundamentals and new directions (NAMEC) - a Villum Kann Rasmussen Centre of Excellence, for financing Ping Li's PhD stipend.

Notes

This box summarizes key points contained in the article.